DOCSLIB.ORG

American Board of Psychiatry and Neurology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
American Board of Psychiatry and Neurology CERTIFICATION EXAMINATION IN CHILD NEUROLOGY 2016 Content Blueprint (October 27, 2015) Part A Basic neuroscience Number of questions: 120 01. Neuroanatomy 3-5% 02. Neuropathology 3-5% 03. Neurochemistry 2-4% 04. Neurophysiology 5-7% 05. Neuroimmunology/neuroinfectious disease 2-4% 06. Neurogenetics/molecular neurology, neuroepidemiology 2-4% 07. Neuroendocrinology 1-2% 08. Neuropharmacology 4-6% Part B Behavioral neurology, cognition, and psychiatry Number of questions: 80 01. Development through the life cycle 3-5% 02. Psychiatric and psychological principles 1-3% 03. Diagnostic procedures 1-3% 04. Clinical and therapeutic aspects of psychiatric disorders 5-7% 05. Clinical and therapeutic aspects of behavioral neurology 5-7% Part C Clinical neurology (adult and child) The clinical neurology section of the Child Neurology Certification Examination is comprised of 70% child neurology questions and 30% adult neurology questions. Number of questions: 200 01. Headache disorders 1-3% 02. Pain disorders 1-3% 03. Epilepsy and episodic disorders 1-3% 04. Sleep disorders 1-3% 05. Genetic disorders 1-3% 06. Congenital disorders 1-3% 07. Cerebrovascular disease 1-3% 08. Neuromuscular diseases 2-4% 09. Cranial nerve palsies 1-3% 10. Spinal cord diseases 1-3% 2016 ABPN Content Specifications Page 1 of 19 Posted: November 12, 2015 Certification in Child Neurology 11. Movement disorders 1-3% 12. Demyelinating diseases 1-3% 13. Neuroinfectious diseases 1-3% 14. Critical care 1-3% 15. Trauma 1-3% 16. Neuro-ophthalmology 1-3% 17. Neuro-otology 1-3% 18. Neurologic complications of systemic diseases 2-4% 19. Neuro-oncology 1-3% 20. Neurotoxicology 1-3% 21. Pregnancy and neurology 1-3% 22. Child neurology specific disorders 2-4% 23. Ethics 1-3% 24. Clinical diagnostic and therapeutic procedures 2-4% 25. Interpersonal and communication skills 1-3% 26. Systems-based practice issues 1-3% TOTAL 100% CERTIFICATION EXAMINATION IN NEUROLOGY 2016 Content Outline Part A Basic neuroscience 01. Neuroanatomy A. Cerebral cortex B. Connecting systems C. Basal ganglia/thalamus D. Brainstem E. Cerebellum F. Cranial nerves G. Spinal cord H. Spinal roots/peripheral nerves I. Ventricular system, CSF J. Vascular K. Neuromuscular junction/muscle L. Autonomic nervous system 2016 ABPN Content Specifications Page 2 of 19 Posted: November 12, 2015 Certification in Child Neurology M. Embryology and neural development N. Pain pathways O. Radiologic anatomy, cerebral blood vessels (angiography or MRA) P. CSF anatomy, physiology, normal and abnormal patterns (cellular, chemical, enzymatic, serologic) Q. Other 02. Neuropathology A. Basic patterns of reaction B. Cerebrovascular disease C. Trauma (cranial and spinal) D. Metabolic/toxic/nutritional diseases E. Infections F. Demyelinating diseases/leukodystrophies G. Neoplasms H. Congenital/developmental anomalies I. Degenerative/heredodegenerative disorders J. Myopathies K. Peripheral nerve L. Neuromuscular junction disorders M. Radiologic pathology pertinent to assigned pathology sections N. Other 03. Neurochemistry A. Carbohydrate metabolism B. Lipid metabolism C. Protein metabolism D. Neurotransmitters E. Axonal transport F. Energy metabolism G. Blood-brain barrier H. Biochemistry of membranes/receptors/ion channels I. Neuronal excitation J. Vitamins (general aspects) K. Inborn errors of metabolism L. Electrolytes and minerals M. Neurotoxins N. Free radical scavengers O. Excitotoxicity P. Normal CSF constituents and volume Q. Other 04. Neurophysiology 2016 ABPN Content Specifications Page 3 of 19 Posted: November 12, 2015 Certification in Child Neurology A. Membrane physiology B. Synaptic transmission C. Sensory receptors and perception D. Special senses E. Reflexes F. Segmental and suprasegmental control of movement G. Cerebellar function H. Reticular system: mechanisms of sleep and arousal, consciousness, circadian rhythms I. Rhinencephalon; limbic system; visceral brain J. Learning and memory K. Cortical organization and function L. Pathophysiology of epilepsy M. Cerebral blood flow N. Autonomic function O. Blood-brain barrier P. Neurophysiology of the visual system Q. Neurophysiology of hearing and vestibular function R. Physiology of pain S. Physiology of peripheral nerve and muscle T. Other 05. Neuroimmunology/neuroinfectious disease A. Molecular pathogenesis of multiple sclerosis B. Molecular neurology of prion and infectious diseases C. Immunotherapy in multiple sclerosis, myasthenia gravis, and other neurologic disorders D. Other 06. Neurogenetics/molecular neurology, and neuroepidemiology A. Mendelian-inherited diseases B. Other modes of inheritance C. Mitochondrial disorders D. Trinucleotide repeat disorders E. Channelopathies F. Genetics of epilepsy G. Risk factors in neurologic disease H. Demographics of neurologic disease 07. Neuroendocrinology A. Thyroid gland B. Cushing syndrome C. Corticosteroids 2016 ABPN Content Specifications Page 4 of 19 Posted: November 12, 2015 Certification in Child Neurology D. Growth hormones E. Hypothalamic function F. Adrenal gland G. Pituitary gland H. Prolactin I. Androgen 08. Neuropharmacology A. General principles of neuropharmacology 1. Neuropharmacokinetics/ neuropharmacodynamics 2. Drug interactions 3. Age, gender, and ethnicity issues B. Anti-seizure medications C. Antibiotics/antimicrobials/vaccines D. Neuromuscular agents (neuromuscular junction) E. Therapeutic agents in movement disorders F. Vitamins (clinical aspects) 1. Vitamin deficiency states a. Vitamin B6 (pyridoxine) deficiency and dependency b. Vitamin B1 (thiamine) deficiency c. Vitamin B₁₂ (cobalamin) deficiency d. Nicotinic acid deficiency (pellagra) e. Biotinidase 2. Vitamin excess a. Hypervitaminosis A b. Hypervitaminosis D c. Vitamin B6 (pyridoxine) excess administration G. Analgesics (non-narcotics, narcotics, and other centrally active agents) H. Anticoagulants, antiplatelets, and thrombolytic agents I. Hormones J. Immunomodulatory and immunosuppressive agents K. Anticholinesterase drugs L. Neurologic side effects of systemic drugs M. Drugs used in cognitive disorders N. Miscellaneous drugs 2016 ABPN Content Specifications Page 5 of 19 Posted: November 12, 2015 Certification in Child Neurology Part B Behavioral neurology, cognition, and psychiatry 01. Development through the life cycle A. Infancy through adolescence, including developmental processes, tasks, crises, and transitions (e.g., school entry, peer relations, individuation) B. Adulthood, including developmental processes, tasks, crises, transitions (e.g., employment, parenting), and acquisition/loss of specific capacities (e.g., menopause) C. Late life, including developmental processes, tasks, crises, transitions, and acquisition/loss of specific capacities (e.g., cognition, physical endurance) 02. Psychiatric and psychological principles A. Cognition, including neuropsychology and cognitive psychology B. Psychological defenses 03. Diagnostic procedures A. Mental status examination B. Cognitive and neuropsychological testing 04. Clinical and therapeutic aspects of psychiatric disorders A. Disorders associated with infancy, childhood, or adolescence 1. Mental retardation (DSM-IV)/intellectual disability (DSM-5) 2. Learning disorders 3. Motor skills disorder 4. Communication disorders 5. Pervasive developmental disorders (DSM-IV)/autism spectrum disorders (DSM-5) 6. Attention-deficit and disruptive behavior disorders 7. Tic disorders 8. Elimination disorders 9. Other B. Schizophrenia and other psychotic disorders 1. Schizophrenia, schizophreniform and schizoaffective disorders 2. Brief psychotic disorder 3. Psychotic disorder due to a general medical condition (DSM- IV)/psychotic disorder due to another medical condition (DSM-5) 4. Substance-induced psychotic disorder (DSM- IV)/substance/medication-induced psychotic disorder (DSM-5) 5. Other C. Mood disorders (DSM-IV)/depressive disorders and bipolar and related disorders (DSM-5) 1. Depressive disorders a. Major depressive disorder b. Dysthymic disorder (DSM-IV)/persistent depressive disorder 2016 ABPN Content Specifications Page 6 of 19 Posted: November 12, 2015 Certification in Child Neurology [dysthymia] (DSM-5) c. Mood disorder due to a general medical condition (DSM- IV)/depressive disorder due to another medical condition (DSM-5) d. Other depressive disorders 2. Bipolar disorders a. Bipolar I disorder b. Bipolar II disorder 3. Other D. Anxiety disorders and obsessive-compulsive and related disorders 1. Panic disorder 2. Obsessive-compulsive disorder 3. Posttraumatic stress disorder 4. Acute stress disorder 5. Generalized anxiety disorder 6. Anxiety disorder due to a general medical condition (DSM-IV)/anxiety disorder due to another medical condition (DSM-5) 7. Substance-induced anxiety disorder (DSM-IV)/ substance/medication- induced anxiety disorder (DSM-5) 8. Other E. Somatoform disorders (DSM-IV)/somatic symptom and related disorders (DSM- 5) 1. Conversion disorder 2. Hypochondriasis (DSM-IV)/somatic symptom disorder (DSM-5) or illness anxiety disorder (DSM-5) 3. Other F. Factitious disorders G. Dissociative disorders 1. Dissociative amnesia 2. Other H. Personality disorders 1. Cluster A 2. Cluster B 3. Cluster C I. Eating disorders (DSM-IV)/feeding and eating disorders (DSM-5) 1. Anorexia nervosa 2. Bulimia nervosa J. Adjustment disorders (DSM-IV)/trauma- and stressor-related disorders (DSM-5) K. Treatment of psychiatric disorders 1. General principles of psychopharmacology 2016 ABPN Content Specifications Page 7 of 19 Posted: November 12, 2015 Certification in Child Neurology a.
Load more

Recommended publications
  • Preventing Inhalant Abuse
    A Parent’s Guide to 800.232.4424 (Voice/TTY) 860.793.9813 (Fax) www.ctclearinghouse.org Preventing Inhalant Abuse A Library and Resource Center on Alcohol, Tobacco, Other Drugs, Mental Health and Wellness Inhalant Abuse: It's Deadly. Inhalant abuse can What are the effects of inhalant abuse? kill. Sniffing can cause sickness and death. For example, It can kill suddenly, and it can kill those who sniff for victims may become nauseated, forgetful, and unable the first time. to see things clearly. Victims may lose control of their body, including the use of arms and legs. These effects Every year, young people in this country die of can last 15 to 45 minutes after sniffing. inhalant abuse. Hundreds suffer severe consequences, including permanent brain damage, loss of muscle In addition, sniffing can severely damage many parts control, and destruction of the heart, blood, kidney, of the body, including the brain, heart, liver, kidneys, liver, nerves, and bone marrow. and nerves. Ordinary household products, which can Even worse, victims can die suddenly -- without any be safely used for legitimate purposes, warning. "Sudden Sniffing Death Syndrome" can occur can be problematic in the hands of an during or right after sniffing. The heart begins to inhalant abuser. overwork, beating rapidly but unevenly, which can lead to cardiac arrest. Even first-time abusers have Today more than 1,000 common household products been known to die from sniffing inhalants. are commonly abused. The National Institute on Drug Abuse reported that one in five American teenagers How can you tell if a young person is an inhalant have used inhalants to get high.
    [Show full text]
  • Inhalant Abuse Pediatric Care
    CLINICAL REPORT Guidance for the Clinician in Rendering Inhalant Abuse Pediatric Care Janet F. Williams, MD, Michael Storck, MD, and the Committee on Substance Abuse and Committee on Native American Child Health ABSTRACT Inhalant abuse is the intentional inhalation of a volatile substance for the purpose of achieving an altered mental state. As an important, yet-underrecognized form of substance abuse, inhalant abuse crosses all demographic, ethnic, and socioeco- nomic boundaries, causing significant morbidity and mortality in school-aged and older children. This clinical report reviews key aspects of inhalant abuse, empha- sizes the need for greater awareness, and offers advice regarding the pediatrician’s role in the prevention and management of this substance abuse problem. TYPES OF CHEMICALS AND PRODUCTS ABUSED The term “inhalant” encompasses a wide range of pharmacologically diverse substances that readily vaporize. Most other substances of abuse are classified by grouping together substances that share a specific central nervous system action or perceived psychoactive effect, but inhalant substances that are abused are grouped by having a common route of drug use. Inhalant abuse, sometimes referred to as solvent or volatile substance abuse, can be better understood when the expansive list of inhalants is classified into 3 groups on the basis of what is currently known pharmacologically: group I includes volatile solvents, fuels, and anesthetics; group II includes nitrous oxide; and group III includes volatile alkyl nitrites (Table 1). This classification is also consistent with reported differences in user populations, patterns of abuse, and associated problems seen clinically.1–3 Drugs that do not www.pediatrics.org/cgi/doi/10.1542/ readily vaporize at room temperature, such as cocaine, heroin, nicotine, or alcohol, peds.2007-0470 can also be abused through inhalation, but characteristic pharmacologic properties doi:10.1542/peds.2007-0470 distinguish these substances from inhalants.
    [Show full text]
  • The Truth About Inhalants (PDF)
    POISONPOISON n © Paul Hardy/CORBIS. n © Paul VAPORS:VAPORS: THETHE TRUTHTRUTH ABOUTABOUT INHALANTSINHALANTS Inhalants can cause harm to the whole body, including long-lasting damage to the brain, physical disabilities, and even death. Photo credits: spray from aerosol can © Hardy/zefa/CORBIS; household products inset © Custom Medical Stock Photo; ball and chai from aerosol can © Hardy/zefa/CORBIS; Photo credits: spray I FROM SCHOLASTIC AND THE SCIENTISTS OF THE NATIONAL INSTITUTE ON DRUG ABUSE, NATIONAL INSTITUTES OF HEALTH, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES WWW.SCHOLASTIC.COM/HEADSUP One Harmful Effect of Inhalants WHAT IS AN INHALANT? Inhalants destroy nerve fibers throughout an inhalant abuser's Inhalants are toxic—that is, poisonous—chemical vapors that can be misused brain, which can lead to muscle to produce mind-altering effects, often with disastrous results. spasms and difficulty with basic These harmful vapors can be found in a variety of common household activities like walking and talking. and office products, including nail polish remover, gasoline, aerosol sprays, How do inhalants destroy nerve correction fluid, whipped cream canisters, computer spray cleaners, paint fibers? Primarily by causing the myelin around them to deteriorate. thinners, and markers. Even when used for their intended purposes, such as Myelin is typically found in a thick cleaning or painting, these products are so toxic that they are recommended layer around the axons, the long for use only in well-ventilated areas. That’s to prevent people from parts of nerve fibers through which accidentally breathing in the poison. When they are intentionally inhaled in impulses flow.
    [Show full text]
  • Inhalant Abuse Prevent Inhalant Abuse: • Keep Victim Calm
    PROTECT YOUR CHILDREN WHAT TO DO WHEN FROM INHALANTS SOMEONE IS HUFFING • Remain calm. INHAlaNt ABuse Prevent inhalant abuse: • Keep victim calm. • Do not argue with user! When someone ■ Talk to your teenagers about the dangers is high on inhalants, stress can cause the of inhalants. heart to stop. ■ Demonstrate safe use of medicines and • If the victim won’t wake up, is not household products. Teach children to breathing, or is having seizures, be careful – these are poisons if used the call 911. wrong way. • If there are other symptoms, or no symptoms, call Poison Control. ■ Include inhalants when you teach about substance abuse (drugs, alcohol,tobacco). TO LEARN MORE ABOUT Inhalants are poisons, pollutants, and fire INHALANTS hazards. But, they have drug-like effects. They can kill if used the wrong way. For a poison emergency, and for ■ Keep track of inhalants in your home. questions about inhalants and Where are they? Are they being used up other poisons: too quickly? Call Poison Control at 1-800-222-1222 or log on to webPOISONCONTROL.org. Detect inhalant abuse: Poison help is free and confidential. Expert ■ Are large quantities of household help is available 24 hours a day. products purchased or missing? What parents need ■ Do you find stashes of plastic bags, smelly to know about rags, or empty containers? ■ Does your child have rashes on the face or INHALANTS a chronic sore throat or mouth? ■ Do you smell a chemical odor on your child’s breath or clothes? ■ Are there other signs of substance abuse? • changes in behavior, friends, grades, or grooming • changes in weight or health for no obvious reason 1-800-222-1222 webPOISONCONTROL.org webPOISONCONTROL.org INHALANT ABUSE THE POISONS ARE RIGHT INHALANTS KILL UNDER YOUR NOSE… What is it? The first time, Inhalant abuse means trying to get high …and also under your sink, in your shed or or any time, by breathing in vapors, fumes, or aero- garage or workroom, in your office, and in sol sprays.
    [Show full text]
  • Hypervitaminosis - an Emerging Pathological Condition
    International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Review Article Hypervitaminosis - An Emerging Pathological Condition J K Roop PG Department of Zoology, JC DAV College (Affiliated to Panjab University, Chandigarh), Dasuya-144205, District Hoshiarpur, Punjab, India ABSTRACT Vitamins are essential organic compounds that are required in small amounts to regulate various metabolic activities in the body. Prolonged and overconsumption of pharmaceutical forms of both water-soluble and fat-soluble vitamins may lead to toxicity and/or hypervitaminosis. Hypervitaminosis is an acute emerging pathological condition of the body due to excess accumulation of any of the vitamins. In case of acute poisoning with vitamin supplements/drugs, emergency assistance is required to detoxify the effects and restore the organization, structure and function of body’s tissues and organs. Sometimes death may occur due to intoxication to liver, kidney and heart. So, to manage any type of hypervitaminosis, proper diagnosis is essential to initiate eliminating the cause of its occurrence and accelerate the elimination of the supplement from the body. The present review discusses the symptoms of hypervitaminosis that seems to be a matter of concern today and management strategies to overcome toxicity or hypervitaminosis. Keywords: Hypervitaminosis, Toxicity, Vitamins, Vitamin pathology, Fat-soluble vitamin, Water- soluble vitamin. INTRODUCTION body, particularly in the liver. Vitamin B Vitamins are potent organic Complex and vitamin C are water- soluble. compounds present in small concentrations They are dissolved easily in food during in various fruits and vegetables. They cooking and a portion of these vitamins may regulate physiological functions and help in be destroyed by heating.
    [Show full text]
  • OREGON LAWS 2015 Chap. 158
    OREGON LAWS 2015 Chap. 158 CHAPTER 158 product is marketed and sold solely for the ap- proved purpose; and AN ACT HB 2546 (ii) Tobacco products. (b) “Tobacco products” means: Relating to inhalants; creating new provisions; (A) Bidis, cigars, cheroots, stogies, periques, amending ORS 163.575, 163.580, 165.800, 165.813, granulated, plug cut, crimp cut, ready rubbed 167.400, 167.401, 167.402, 167.404, 167.407, 339.883, and other smoking tobacco, snuff, snuff flour, 421.352, 431.840, 431.845, 431.853, 433.835, 433.840, cavendish, plug and twist tobacco, fine-cut and 433.845, 433.847, 433.850, 433.855, 433.870, 441.815, other chewing tobaccos, shorts, refuse scraps, 565.456, 807.500 and 811.193; repealing ORS clippings, cuttings and sweepings of tobacco and 192.710, 192.990, 243.345 and 243.350; and declar- other forms of tobacco, prepared in a manner ing an emergency. that makes the tobacco suitable for chewing or Be It Enacted by the People of the State of Or- smoking in a pipe or otherwise, or for both egon: chewing and smoking; or (B) Cigarettes as defined in ORS 323.010 (1). SALES AND DISTRIBUTION (2) It is unlawful: (a) To distribute, sell or allow to be sold to- bacco products or an inhalant delivery system to a person under 18 years of age. SECTION 1. ORS 431.840, as amended by sec- (b) To fail as a retailer of tobacco products tion 2, chapter 20, Oregon Laws 2014, is amended to to post a notice substantially similar to the no- read: tice described in subsection (3) of this section in 431.840.
    [Show full text]
  • The Practice and Regulatory Requirements Of
    School of Public Health The Practice and Regulatory Requirements of Naturopathy and Western Herbal Medicine Vivian Lin Alan Bensoussan Stephen P. Myers Pauline McCabe Marc Cohen Sophie Hill Genevieve Howse November, 2005 Funded by the Department of Human Services, Victoria Copyright State of Victoria, Department of Human Services, 2006 This publication is copyright. No part may be reproduced by any process except in accordance with the provisions of the Copyright Act 1968 (Cth). Authorised by the State Government of Victoria, 50 Lonsdale Street Melbourne. This document may be downloaded from the following website: www.health.vic.gov.au/pracreg/naturopathy.htm ISBN-13: 978-0-9775864-0-0 ISBN-10: 0-9775864-0-5 Published by School of Public Health, La Trobe University Bundoora Victoria, 3086 Australia THE PRACTICE AND REGULATORY REQUIREMENTS OF NATUROPATHY AND WESTERN HERBAL MEDICINE CONTENTS VOLUME ONE Summary Report..........................................................................................................1 1. Introduction.......................................................................................................1 2. Methodology.....................................................................................................1 3. Key findings and recommendations..................................................................2 3.1 Definition of practice and scope of study ........................................................2 3.2 Growing use of naturopathy and WHM...........................................................3
    [Show full text]
  • Hepatic Pathology in Vitamin a Toxicity FAIRPOUR FOROUHAR, M.D.* MARTIN S
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 14, No. 4 Copyright © 1984, Institute for Clinical Science, Inc. Hepatic Pathology in Vitamin A Toxicity FAIRPOUR FOROUHAR, M.D.* MARTIN S. NADEL, M.D.,t and BERNARD GONDOS, M.D.* *Department of Pathology, University of Connecticut, Farmington, CT 06032 and fDepartment of Pathology, Middlesex Memorial Hospital, Middletown, CT 06457 ABSTRACT This paper documents a case of vitamin A toxicity presenting with splenomegaly and ascites. The light microscopic, electron microscopic, and fluorescent findings are described in detail. The principal histopath­ ologic finding was marked perisinusoidal fibrosis. The role of Ito cells in the storage of lipid-soluble vitamins and their subsequent transformation to fibroblasts producing collagen are discussed. tient denied use of medications but admitted long Introduction time use of a self-prescribed vitamin B1-B6 combi­ nation, vitamin B12, iodine, and garlic. Vitamin A Liver disease resulting from vitamin A had been taken for six years, initially 75,000 units toxicity is an uncommon but well docu­ daily, increased to 150,000 units daily two years prior to admission because of believed problems with night mented entity.6’1414’22’26,27 The present vision for which no medical help had been sought. case provides a good model for the study Physical examination disclosed no palpable spleno­ of fibrosis of the space of Disse and its megaly with liver felt one cm beneath the right costal margin. An abdominal fluid wave was present. No pathophysiologic ^consequences. Similar spider angiomata were noted, and the remainder of changes also occur in other conditions re­ the physical examination was unremarkable.
    [Show full text]
  • Assessing the Nutritional Value of Black Soldier Fly Larvae (Hermetia Illucens) Used for Reptile Foods Kimberly L
    Louisiana State University LSU Digital Commons LSU Master's Theses Graduate School April 2019 Assessing the Nutritional Value of Black Soldier Fly Larvae (Hermetia illucens) Used for Reptile Foods Kimberly L. Boykin Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_theses Part of the Other Veterinary Medicine Commons Recommended Citation Boykin, Kimberly L., "Assessing the Nutritional Value of Black Soldier Fly Larvae (Hermetia illucens) Used for Reptile Foods" (2019). LSU Master's Theses. 4927. https://digitalcommons.lsu.edu/gradschool_theses/4927 This Thesis is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Master's Theses by an authorized graduate school editor of LSU Digital Commons. For more information, please contact [email protected]. ASSESSING THE NUTRITIONAL VALUE OF BLACK SOLDIER FLY LARVAE (HERMETIA ILLUCENS) USED FOR REPTILE FOODS A Thesis Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Master of Science in The Department of Veterinary Sciences by Kimberly Lynne Boykin B.S., Florida State University, 2008 D.V.M., North Carolina State University, 2016 May 2019 ACKNOWLEDGEMENTS I am greatly indebted to a number of individuals whose expertise and support have been instrumental in helping me reach the completion of my thesis research. Foremost, I would like to express my sincerest gratitude to my major professor/advisor/ life coach, Dr. Mark Mitchell. If it were not for his continued enthusiasm, motivation, and guidance, I would not be where I am today.
    [Show full text]
  • Inhalant Use Disorder
    Inhalant Use Disorder 1) Which of the following is the definition of volatile? a) The ability to evaporate and form a vapor. b) Resistance to flow. c) Decrease in temperature when compressed. d) The ability to change from a gas to a liquid. 2) Which of the following are commonly abused in inhalant use disorder? a) Cocaine, gasoline. b) Typewriter correction fluid, spray paint. c) Paint thinner, methamphetamine. d) Water-based paint, paint strippers. 3) Volatile solvents are a) slowly absorbed through the gut. b) rapidly absorbed through the skin c) usually injected d) rapidly absorbed through the lungs. 4) Which of these terms describe how inhalants are used? a) Bagging, huffing, and sniffing. b) Snorting, smoking, and gumming. c) Shooting, huffing, and rocking. d) Bagging, amping, and freebasing. ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 5) Which of the following is a common effect of acute inhalant intoxication? a) Myocardial infarction. b) Drowsiness. c) Congestive heart failure. d) Liver damage. 6) Common pulmonary effects of acute inhalant intoxication can include a) left to right shunt. b) atelectasis. c) pneumothorax d) respiratory depression. 7) Pulmonary effects of acute inhalant intoxication can include a) airway damage. b) tracheo-esophageal fistula. c) pulmonary fibrosis. d) viral infections. 8) Inhalants that contain methylene chloride can cause a) carbon monoxide poisoning. b) methemoglobinemia. c) renal tubular acidosis. d) hyperkalemia and hyponatremia. ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com 9) Sudden death cause by inhalant use a) very common. b) happens only to young females.
    [Show full text]
  • House Bill 2261 Sponsored by Representative MARSH, Senator TAYLOR (At the Request of Attorney General Ellen F
    81st OREGON LEGISLATIVE ASSEMBLY--2021 Regular Session House Bill 2261 Sponsored by Representative MARSH, Senator TAYLOR (at the request of Attorney General Ellen F. Rosenblum) (Presession filed.) SUMMARY The following summary is not prepared by the sponsors of the measure and is not a part of the body thereof subject to consideration by the Legislative Assembly. It is an editor’s brief statement of the essential features of the measure as introduced. Prohibits remote sales of inhalant delivery systems. Defines “inhalant delivery system.” Substi- tutes “21 years of age” for “the legal minimum purchase age.” Requires tobacco retailer to obtain local license if operating in jurisdiction with local license requirement. 1 A BILL FOR AN ACT 2 Relating to items for which a person must obtain a minimum age to purchase; creating new pro- 3 visions; amending ORS 167.760, 180.405, 180.441, 180.451, 180.468, 323.700, 323.703, 323.706, 4 323.709, 323.712, 323.715 and 323.724; and repealing ORS 323.718. 5 Be It Enacted by the People of the State of Oregon: 6 SECTION 1. ORS 167.760 is amended to read: 7 167.760. (1) Except as provided in subsection (2) of this section, a person under 21 years of age 8 may not purchase or attempt to purchase tobacco products or an inhalant delivery system. 9 (2) A person under 21 years of age who is acting under the supervision of a person 21 years of 10 age or older may purchase or attempt to purchase tobacco products or an inhalant delivery system 11 for the purpose of testing compliance with a federal law, state law, local law or retailer policy lim- 12 iting or regulating the distribution or sale of tobacco products or inhalant delivery systems to per- 13 sons who are under [the legal minimum purchase age] 21 years of age.
    [Show full text]
  • Inhalant Delivery System Laws and Rules Report to the 2019 Oregon Legislature Review of Scientific Evidence and Regulatory Context
    2019 Inhalant Delivery System Laws and Rules Report to the 2019 Oregon Legislature Review of Scientific Evidence and Regulatory Context PUBLIC HEALTH DIVISION Acknowledgments This publication was prepared by the Health Promotion and Chronic Disease Prevention Section of the Oregon Health Authority Public Health Division, including: Sharon Coryell, MPH Sarah Hargand, MPH Tara Weston, MPH Sarah Wylie, MPH Oversight provided by: Thomas Jeanne, MD, MPH Todd Beran, MA This report relied on the efforts of additional Oregon Public Health Division Staff, including: Anne Celovsky, MPH Meghan Mccausland, MPH Beth Vorderstrasse, MPH In addition, we are grateful for the review and contributions of the following people: Shannon O’Fallon, JD, Oregon Department of Justice Michael Tynan, MA, Centers for Disease Control and Prevention – Office on Smoking and Health Brian King, PhD, Centers for Disease Control and Prevention – Office on Smoking and Health The content of this report draws from extensive literature reviews completed recently by the National Academy of Sciences and the U.S. Department of Health and Human Services. These reports are cited here and throughout this report as appropriate. U.S. Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults. A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2016. National Academy of Sciences. Public Health Consequences of E-Cigarettes. A consensus study report of the National Academies of Sciences, Engineering, and Medicine. Washington, D.C. National Academy of Sciences, Board on Population Health and Public Health Practice, Health and Medicine Division, 2018.
    [Show full text]